Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-22T15:13:32.889Z Has data issue: false hasContentIssue false
  • English
  • Français

Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak

Published online by Cambridge University Press:  15 May 2009

C. F. Pegues ,
D. A. Pegues ,
D. S. Ford ,
P. L. Hibberd ,
L. A. Carson ,
C. M. Raine  and
D. C. Hooper
C. F. Pegues
Affiliation:
Infection Control Unit, Massachusetts General Hospital, Boston, MA
D. A. Pegues
Affiliation:
Infectious Disease Unit, Massachusetts General Hospital, Boston, MA
D. S. Ford
Affiliation:
Infection Control Unit, Massachusetts General Hospital, Boston, MA
P. L. Hibberd
Affiliation:
Infection Control Unit, Massachusetts General Hospital, Boston, MA Infectious Disease Unit, Massachusetts General Hospital, Boston, MA
L. A. Carson
Affiliation:
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, GA
C. M. Raine
Affiliation:
Infection Control Unit, Massachusetts General Hospital, Boston, MA
D. C. Hooper*
Affiliation:
Infection Control Unit, Massachusetts General Hospital, Boston, MA Infectious Disease Unit, Massachusetts General Hospital, Boston, MA
*
* Address for correspondence: David C. Hooper, MD, Infectious Disease Unit, Gray 5, 32 Fruit St., Massachusetts General Hospital, Boston, MA 02114USA.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In 1994 we investigated a large outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract acquisition. A case patient was defined as any patient with at least one sputum culture from which B. cepacia was isolated from 1 January to 31 December 1994. Seventy cases were identified. Most (40 [61 %]) occurred between 1 February and 31 March 1994; of these, 35 (86%) were mechanically ventilated patients, 30 of whom were in an intensive-care unit (ICU) when B. cepacia was first isolated. Compared with control patients who were mechanically ventilated in an ICU, these 30 case-patients were significantly more likely to have been ventilated for 2 or more days (30/30 v. 15/30; P < 0·001) or to have been intubated more than once (12/30 v. 2/30; OR = 9·3, 95% CI 1·6–68·8; P = 0·002) before the first isolation of B. cepacia. By multivariate analysis, the 35 mechanically ventilated case-patients were significantly more likely to have received a nebulized medication (OR = 11·9, 95% CI = 1·6–553·1; P < 0·001) and a cephalosporin antimicrobial (OR = 11·9, 95% CI = 1·6–553·1) in the 10 days before the first isolation of B. cepacia, compared with B. cepacia-negative control-patients matched by date and duration of most recent mechanical ventilation. Although B. cepacia was not cultured from medications or the hospital environment, all outbreak strains tested had an identical DNA restriction endonuclease digestion pattern by pulsed-field gel electrophoresis. Review of respiratory therapy procedures revealed opportunities for contamination of nebulizer reservoirs. This investigation suggests that careful adherence to standard procedures for administration of nebulized medications is essential to prevent nosocomial respiratory infections.

Type
Special Article
Information
Epidemiology & Infection , Volume 116 , Issue 3 , June 1996 , pp. 309 - 317
Copyright
Copyright © Cambridge University Press 1996

References

REFERENCES

1.Isles, A, Maclusky, I, Corey, M et al. , Pseudomonas cepacia infection in cystic fibrosis patients: an emerging problem. J Pediatr 1984; 104: 206–10.CrossRefGoogle ScholarPubMed
2.Thomassen, MJ, Demko, CA, Klinger, JD, Stern, RC. Pseudomonas cepacia colonization among patients with cystic fibrosis: a new opportunist. Am Rev Respir Dis 1985; 131: 791–6.Google ScholarPubMed
3.Tablan, OC, Chorba, TL, Schidlow, DV et al. , Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985; 107: 382–7.CrossRefGoogle ScholarPubMed
4.Tablan, OC, Martone, WJ, Doershuk, CF et al. , Risk factors and clinical outcome associated with Pseudomonas cepacia colonization of the respiratory tract of patients with cystic fibrosis. Chest 1987; 91: 527–33.CrossRefGoogle Scholar
5.Simmonds, EJ, Conway, SP, Ghoneim, ATM, Ross, H, Littlewood, JM. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child 1990; 655: 874–7.CrossRefGoogle Scholar
6.Tablan, OC, Martone, WJ, Jarvis, WR. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis. Eur J Epidemiol 1987; 3: 336–42.CrossRefGoogle ScholarPubMed
7.Pegues, DA, Schidlow, DV, Tablan, OC et al. , Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis. Arch Pediatr Adolesc Med 1994; 148: 805–12.CrossRefGoogle ScholarPubMed
8.Jarvis, WR, Olson, D, Tablan, O, Martone, WJ. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol 1987; 3: 233–6.CrossRefGoogle ScholarPubMed
9.Burdge, DR, Nakielna, EM, Noble, MA. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 1993; 14: 127–30.CrossRefGoogle ScholarPubMed
10.Weems, JJ Jr. Nosocomial outbreak of Pseudomonas cepacia associated with contamination of reusable electronic ventilator temperature probes. Infect Control Hosp Epidemiol 1993; 14: 583–62.CrossRefGoogle ScholarPubMed
11.Weber, DJ, Wilson, B, Rutala, WA, Thomann, CA. Manual ventilation bags as a source for bacterial colonization of intubated patients. Am Rev Respir Dis 1990; 142: 892–4.CrossRefGoogle ScholarPubMed
12.Centers for Disease Control. Pseudomonas cepacia colonization - Minnesota. MMWR 1981; 28: 289–90.Google Scholar
13.Martone, WJ, Tablan, OC, Jarvis, WR. The epidemiology of nosocomial epidemic Pseudomonas cepacia infections. Eur J Epidemiol 1987; 3: 222–32.CrossRefGoogle ScholarPubMed
14.Pierce, AK, Sanford, JP, Thomas, GD, Leonard, JS. Long-term evaluation of decontamination of inhalation-therapy equipment and the occurrence of necrotizing pneumonia. N Engl J Med 1970; 292: 528–31.CrossRefGoogle Scholar
15.Conly, JM, Klass, L, Larson, L et al. , Pseudomonas cepacia colonization and infection in intensive care units. J Can Med Assoc 1986; 134: 363–6.Google ScholarPubMed
16.Martone, WJ, Ostermann, CA, Fisher, KA, Wenzel, RB. Pseudomonas cepacia: implications and control of epidemic nosocomial colonization. Rev Infect Dis 1981; 3: 708–15.CrossRefGoogle ScholarPubMed
17.Mastro, TD, Fields, BS, Breiman, RF et al. , Nosocomial Legionnaire's disease and use of medication nebulizers. J Infect Dis 1991; 163: 667–71.CrossRefGoogle ScholarPubMed
18.Craven, DE, Lichtenberg, DA, Goularte, TA, Make, BJ, McCabe, WR. Contaminated medication nebulizers in mechanical ventilator circuits: source of bacterial aerosols. Am J Med 1984; 77: 834–8.CrossRefGoogle ScholarPubMed
19.Sanders, CV, Luby, JP, Johanson, WG, Barnett, JA, Sanford, JP. Serratia marcescens infections from inhalation therapy medications:nosocomial outbreak. Ann Intern Med 1970; 73: 15–21.CrossRefGoogle ScholarPubMed
20.Hamill, RJ, Houston, ED, Georghiou, PR et al. , An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995; 122: 762–6.CrossRefGoogle ScholarPubMed
21.National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing. Vol. 10. NCCLS document M2-A4. Villanova, Pennsylvania: NCCLS, 1990.Google Scholar
22.Smith, CL, Cantor, CR. Purification, specific fragmentation, and separation of large DNA molecules. In: Methods in enzymology, Wu, R, ed. vol. 155. San Diego, California: Academic Press, Inc., 1987: 449–67.Google Scholar
23.Dean, AG, Dean, JA, Coulombier, D et al. , Epi Info, Version 6.01: a word processing, database and statistics program for epidemiology on microcomputers. Georgia: Centers for Disease Control and Prevention, Atlanta, 1994.Google Scholar
24.Kleinbaum, D, Kupper, L, Morgenstern, H. Observational Research. Belmont, California: Lifetime Learning Publications, 1982.Google Scholar
25.Horan, TC, White, JW, Jarvis, WR et al. , Nosocomial infection surveillance, 1984. MMWR 1986; 35: 17ss–29ss.Google ScholarPubMed
26.Knaus, WA, Wagner, DP, Draper, EA et al. , The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619–36.CrossRefGoogle ScholarPubMed
27.Craven, DE, Kunches, LM, Kilinsky, V et al. , Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Resp Dis 1986; 133: 792–6.Google ScholarPubMed
28.George, DL. Epidemiology of nosocomial ventilator-associated pneumonia. Infect Control Hosp Epidemiol 1993; 14: 163–9.CrossRefGoogle ScholarPubMed
29.Fagon, JY, Chastre, J, Hance, AJ et al. , Evaluation of clinical judgement in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest 1993; 103: 547–53.CrossRefGoogle Scholar
30.Grieble, HG, Colton, RF, Bird, TJ, Toigo, A, Griffith, LG. Fine particle humidifiers: source of Pseudomonas aeruginosa infections in a respiratory disease unit. N Engl J Med 1970; 282: 531–5.CrossRefGoogle Scholar
31.Centers for Disease Control and Prevention. Guideline for prevention of nosocomial pneumonia. Amer J Infect Control 1994; 22: 247–92.Google Scholar